OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Alzheimers Disease & Parkinsonism received 3123 citations as per Google Scholar report
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Year wise published articles |
36 | 33 | 60 | 30 | 45 | 44 | 107 | 89 |
Year wise citations received |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 3123 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2018 | 22 |
Nanotoxicity and Risk Assessment |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Modulation of the microbiota-gut-brain axis by bioactive food, prebiotics, and probiotics decelerates the course of Alzheimer's disease |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimers Disease |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimers Disease in Mice |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Roles of Gut Microbiota in Pathogenesis of Alzheimers Disease and Therapeutic Effects of Chinese Medicine |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Implications of the Human GutBrain and GutCancer Axes for Future Nanomedicine |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Crosstalk between Gut and Brain in Alzheimers Disease: The Role of Gut Microbiota Modulation Strategies |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Dysbiosis and Alzheimers Disease: A Role for Chronic Stress? |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Alternative Anti-Infective / Anti-Inflammatory Therapeutic Options for Fighting Alzheimers Disease |
|
View at Publisher | View at Google Scholar | View at Indexing | |
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? |
|
View at Publisher | View at Google Scholar | View at Indexing | |
The MicrobiotaGutBrain Axis and Alzheimers Disease: Neuroinflammation Is to Blame? |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (A?42) Peptide |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Cell surface amyloid proteins of microorganisms: structure, properties and significance in medicine |
|
View at Publisher | View at Google Scholar | View at Indexing | |
The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure |
|
View at Publisher | View at Google Scholar | View at Indexing | |
A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Age-related cerebral small vessel disease and inflammaging |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Systemic Immune Dyshomeostasis Model and Pathways in Alzheimers Disease |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimers Disease (AD) |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC |
|
View at Publisher | View at Google Scholar | View at Indexing | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals